Amyotrophic Lateral Sclerosis Therapy Development Institute
The ALS Therapy Development Institute is a non-profit biotechnology research organization focused on finding treatments for amyotrophic lateral sclerosis. With a staff including more than 30 scientists, it operates a research and development program centered on ALS. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amyotrophic Lateral Sclerosis Therapy Development Institute, United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
77%
Total
Publications
52
Total Open
Publications
40
Total
Citations
4.5K
Open Access
Percentage
77%
Total
Publications
52
Total Open
Publications
40
Total
Citations
4.5K
Breakdown
Publisher Open
16%
Both
44%
Other Platform Open
17%
Closed
23%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
16
Hybrid 19%
6
No Guarantees 29%
9
Other Platform Open
Domain 84%
27
Other Internet 25%
8
Preprint 22%
7
Public 16%
5
Institution 6%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 27 |
Europe PMC | Domain | 18 |
Semantic Scholar | Public | 5 |
DOI | Other Internet | 5 |
medRxiv | Preprint | 3 |
California Digital Library - eScholarship | Other Internet | 3 |
bioRxiv | Preprint | 3 |
Virginia Tech - Virginia Tech Works | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
arXiv | Preprint | 1 |